Cargando…
Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
We selected fifty one drugs already known for their potential disease treatment roles in various studies and subjected to docking and molecular docking simulation (MDS) analyses. Five of them showed promising features that are discussed and suggested as potential candidates for repurposing for COVID...
Autores principales: | Bhanu1, Piyush, Setlur, Anagha S, K, Chandrashekar, Niranjan, Vidya, Hemandhar Kumar, Nisha, Buchke, Sakshi, Kumar, Jitendra, Rani, Anita, Tiwari, Sushil M, Mishra, Vachaspati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560309/ https://www.ncbi.nlm.nih.gov/pubmed/37814677 http://dx.doi.org/10.6026/97320630019149 |
Ejemplares similares
-
Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020) -
Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
por: Ahmad, Shaban, et al.
Publicado: (2022) -
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022) -
Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022) -
Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders
por: Buchke, Sakshi, et al.
Publicado: (2022)